Jul 22, 2020
Glenmark: Phase-3 trial of antiviral Favipavir shows significant faster time to clinical improvement
Glenmark Pharmaceuticals Ltd announced on Wednesday that the phase-3 clinical trial of Favipiravir in patients with mild-to-moderate COVID-19 demonstr
Read more
Previous